AIM: Cerebral white matter hyperintensities (WMHs), comprising periventricular hyperintensity (PVH) and deep and subcortical white matter hyperintensity (DSWMH) on magnetic resonance imaging (MRI), have been reported to be markers of ischaemic cerebral small-vessel disease and risk factors for future stroke, cognitive impairment and dementia in the general population. However, there have been only a few reports describing WMHs in haemodialysis (HD) patients and these previous studies have been relatively small population studies with little investigation on prevalence and risk factors according to the regional subtypes of WMHs. METHODS: Cranial MRI was performed on 179 HD patients and 58 healthy control subjects and we investigated the prevalence of WMHs (PVH and/or DSWMH) and the clinical factors associated with the presence of WMHs. RESULTS: The prevalence of WMHs was significantly higher in the HD patients than in the healthy subjects. In the HD patients, multiple logistic regression analysis showed that independent and significant factors associated with the presence of PVH were age, female gender and systolic blood pressure and those associated with the presence of DSWMH were age, female gender, systolic blood pressure and body mass index. CONCLUSIONS: These findings indicated a high prevalence of WMHs in HD patients. Older age, female gender and high blood pressure were strong factors associated with the presence of both PVH and DSWMH. Moreover, excess body weight was a significant factor associated with the presence of DSWMH only, indicating that there may be differences in risk factors according to the subtype of WMHs.
AIM: Cerebral white matter hyperintensities (WMHs), comprising periventricular hyperintensity (PVH) and deep and subcortical white matter hyperintensity (DSWMH) on magnetic resonance imaging (MRI), have been reported to be markers of ischaemic cerebral small-vessel disease and risk factors for future stroke, cognitive impairment and dementia in the general population. However, there have been only a few reports describing WMHs in haemodialysis (HD) patients and these previous studies have been relatively small population studies with little investigation on prevalence and risk factors according to the regional subtypes of WMHs. METHODS: Cranial MRI was performed on 179 HDpatients and 58 healthy control subjects and we investigated the prevalence of WMHs (PVH and/or DSWMH) and the clinical factors associated with the presence of WMHs. RESULTS: The prevalence of WMHs was significantly higher in the HDpatients than in the healthy subjects. In the HDpatients, multiple logistic regression analysis showed that independent and significant factors associated with the presence of PVH were age, female gender and systolic blood pressure and those associated with the presence of DSWMH were age, female gender, systolic blood pressure and body mass index. CONCLUSIONS: These findings indicated a high prevalence of WMHs in HDpatients. Older age, female gender and high blood pressure were strong factors associated with the presence of both PVH and DSWMH. Moreover, excess body weight was a significant factor associated with the presence of DSWMH only, indicating that there may be differences in risk factors according to the subtype of WMHs.
Authors: Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman Journal: Nephrol Dial Transplant Date: 2015-02-26 Impact factor: 5.992
Authors: Mark Duncan Findlay; Jesse Dawson; David Alexander Dickie; Kirsten P Forbes; Deborah McGlynn; Terry Quinn; Patrick B Mark Journal: J Am Soc Nephrol Date: 2018-12-07 Impact factor: 10.121
Authors: Cathy R Zhang; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Alison M Ayres; Karen L Furie; Jonathan Rosand; Natalia S Rost Journal: J Stroke Cerebrovasc Dis Date: 2014-11-06 Impact factor: 2.136
Authors: Piotr Olczyk; Mariusz Kusztal; Tomasz Gołębiowski; Krzysztof Letachowicz; Magdalena Krajewska Journal: Int J Environ Res Public Health Date: 2022-02-18 Impact factor: 3.390
Authors: Erum A Hartung; Guray Erus; Abbas F Jawad; Nina Laney; Jimit J Doshi; Stephen R Hooper; Jerilynn Radcliffe; Christos Davatzikos; Susan L Furth Journal: Am J Kidney Dis Date: 2018-02-15 Impact factor: 8.860
Authors: Divya G Moodalbail; Kathryn A Reiser; John A Detre; Robert T Schultz; John D Herrington; Christos Davatzikos; Jimit J Doshi; Guray Erus; Hua-Shan Liu; Jerilynn Radcliffe; Susan L Furth; Stephen R Hooper Journal: Clin J Am Soc Nephrol Date: 2013-05-30 Impact factor: 8.237